Literature DB >> 32469139

Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21.

Richa Sharma1, Matthew M Klairmont2, Ashley C Holland1, John K Choi2, Charles G Mullighan2, Lu Wang2, John T Sandlund1, Ching-Hon Pui1, Hiroto Inaba1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32469139      PMCID： PMC7674224          DOI： 10.1002/pbc.28357

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  13 in total

1.  Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.

Authors:  H M Robinson; Z J Broadfield; K L Cheung; L Harewood; R L Harris; G R Jalali; M Martineau; A V Moorman; K E Taylor; S Richards; C Mitchell; C J Harrison
Journal:  Leukemia       Date:  2003-11       Impact factor: 11.528

Review 2.  Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases.

Authors:  L Harewood; H Robinson; R Harris; M Jabbar Al-Obaidi; G R Jalali; M Martineau; A V Moorman; N Sumption; S Richards; C Mitchell; C J Harrison
Journal:  Leukemia       Date:  2003-03       Impact factor: 11.528

3.  Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.

Authors:  A Attarbaschi; R Panzer-Grümayer; G Mann; A Möricke; M König; A Mecklenbräuker; A Teigler-Schlegel; J Bradtke; J Harbott; G Göhring; M Stanulla; M Schrappe; M Zimmermann; O A Haas
Journal:  Klin Padiatr       Date:  2014-11-28       Impact factor: 1.349

Review 4.  Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.

Authors:  Christine J Harrison
Journal:  Blood       Date:  2015-01-21       Impact factor: 22.113

5.  Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

Authors:  Andishe Attarbaschi; Georg Mann; Renate Panzer-Grümayer; Silja Röttgers; Manuel Steiner; Margit König; Eva Csinady; Michael N Dworzak; Markus Seidel; Dasa Janousek; Anja Möricke; Carsten Reichelt; Jochen Harbott; Martin Schrappe; Helmut Gadner; Oskar A Haas
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

6.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

7.  Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.

Authors:  Nyla A Heerema; Andrew J Carroll; Meenakshi Devidas; Mignon L Loh; Michael J Borowitz; Julie M Gastier-Foster; Eric C Larsen; Leonard A Mattano; Kelly W Maloney; Cheryl L Willman; Brent L Wood; Naomi J Winick; William L Carroll; Stephen P Hunger; Elizabeth A Raetz
Journal:  J Clin Oncol       Date:  2013-08-12       Impact factor: 44.544

8.  Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).

Authors:  Anthony V Moorman; Susan M Richards; Hazel M Robinson; Jon C Strefford; Brenda E S Gibson; Sally E Kinsey; Tim O B Eden; Ajay J Vora; Christopher D Mitchell; Christine J Harrison
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

9.  Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.

Authors:  Jon C Strefford; Frederik W van Delft; Hazel M Robinson; Helen Worley; Olga Yiannikouris; Rebecca Selzer; Todd Richmond; Ian Hann; Tony Bellotti; Manoj Raghavan; Bryan D Young; Vaskar Saha; Christine J Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-15       Impact factor: 11.205

10.  An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.

Authors:  C J Harrison; A V Moorman; C Schwab; A J Carroll; E A Raetz; M Devidas; S Strehl; K Nebral; J Harbott; A Teigler-Schlegel; M Zimmerman; N Dastuge; A Baruchel; J Soulier; M-F Auclerc; A Attarbaschi; G Mann; B Stark; G Cazzaniga; L Chilton; P Vandenberghe; E Forestier; I Haltrich; S C Raimondi; M Parihar; J-P Bourquin; J Tchinda; C Haferlach; A Vora; S P Hunger; N A Heerema; O A Haas
Journal:  Leukemia       Date:  2013-10-29       Impact factor: 11.528
View more
  1 in total

1.  Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement.

Authors:  Emma Kroeze; Laura Arias Padilla; Max Bakker; Judith M Boer; Melanie M Hagleitner; Birgit Burkhardt; Takeshi Mori; Andishe Attarbaschi; Jaime Verdú-Amorós; Marta Pillon; Liliya Anderzhanova; Edita Kabíčková; Alan K S Chiang; Rejin Kebudi; Karin Mellgren; Jelena Lazic; Janez Jazbec; Jules P P Meijerink; Auke Beishuizen; Jan L C Loeffen
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.